Physician profile
Faris Haddadin
NPI 1568985935
$13,282.89
in general payments reported to CMS, 2019-2025
10 companies · $2,521 in 2025
The $2,521 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $125 · 2024: $11K · 2025: $2,521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Food and Beverage: $1,911 · Travel and Lodging: $963 · Education: $408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Food and Beverage | $1,911.42 |
| Travel and Lodging | $963.10 |
| Education | $408.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $10,323.01 | 2024-2025 | Farapulse |
| Philips North America LLC | $1,130.68 | 2023-2025 | Lm Undivided, Igt Devices Undivided, (7881) Ultrasound Und |
| Medtronic, INC. | $935.03 | 2024-2025 | Micra, Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| Biosense Webster, INC. | $301.44 | 2025 | Carto 3, Qdot Micro |
| Biotronik INC. | $286.19 | 2024 | Acticor 7 Vr-T Dx, Amvia Edge |
| Abbott Laboratories | $153.15 | 2025 | Ensite |
| Pfizer INC. | $59.06 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $44.14 | 2025 | Lifevest |
| Baxter Healthcare | $31.15 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Actelion Pharmaceuticals US, INC. | $19.04 | 2025 | Opsumit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faris Haddadin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.